Study Details

Back
Study ID 4070-CL-0010
Study Title A Phase 1 Study of ASP4070 to Confirm the Safety and Immunological Response in Patients With Cedar Pollinosis When Administered as Intramuscular Vaccination and as Intradermal Vaccination
Clinicaltrials.gov Identifier NCT02469688
Compound Name ASP4070
Medical Indication or Disease Pollinosis
Study Sponsor Astellas Pharma Inc.
Collaborator Immunomic Therapeutics, Inc.
Study Start Date 18-Jun-2015
Study Completion Date 26-Jul-2016
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
Japanese

QUICK SEARCH

USEFUL LINKS